Cargando…
Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028030/ https://www.ncbi.nlm.nih.gov/pubmed/31429969 http://dx.doi.org/10.1002/hep.30904 |
| _version_ | 1783498942864949248 |
|---|---|
| author | Arase, Yoshitaka Tsuruya, Kota Hirose, Shunji Ogiwara, Naoki Yokota, Masashi Anzai, Kazuya Deguchi, Ryuzo Shiraishi, Koichi Shirai, Takayuki Kagawa, Tatehiro |
| author_facet | Arase, Yoshitaka Tsuruya, Kota Hirose, Shunji Ogiwara, Naoki Yokota, Masashi Anzai, Kazuya Deguchi, Ryuzo Shiraishi, Koichi Shirai, Takayuki Kagawa, Tatehiro |
| author_sort | Arase, Yoshitaka |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7028030 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70280302020-02-25 Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases Arase, Yoshitaka Tsuruya, Kota Hirose, Shunji Ogiwara, Naoki Yokota, Masashi Anzai, Kazuya Deguchi, Ryuzo Shiraishi, Koichi Shirai, Takayuki Kagawa, Tatehiro Hepatology Clinical Observations in Hepatology John Wiley and Sons Inc. 2019-10-10 2020-02 /pmc/articles/PMC7028030/ /pubmed/31429969 http://dx.doi.org/10.1002/hep.30904 Text en © 2019 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Clinical Observations in Hepatology Arase, Yoshitaka Tsuruya, Kota Hirose, Shunji Ogiwara, Naoki Yokota, Masashi Anzai, Kazuya Deguchi, Ryuzo Shiraishi, Koichi Shirai, Takayuki Kagawa, Tatehiro Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases |
| title | Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases |
| title_full | Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases |
| title_fullStr | Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases |
| title_full_unstemmed | Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases |
| title_short | Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases |
| title_sort | efficacy and safety of 3‐year denosumab therapy for osteoporosis in patients with autoimmune liver diseases |
| topic | Clinical Observations in Hepatology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028030/ https://www.ncbi.nlm.nih.gov/pubmed/31429969 http://dx.doi.org/10.1002/hep.30904 |
| work_keys_str_mv | AT araseyoshitaka efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT tsuruyakota efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT hiroseshunji efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT ogiwaranaoki efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT yokotamasashi efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT anzaikazuya efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT deguchiryuzo efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT shiraishikoichi efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT shiraitakayuki efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases AT kagawatatehiro efficacyandsafetyof3yeardenosumabtherapyforosteoporosisinpatientswithautoimmuneliverdiseases |